The Global Cardiac Arrhythmia Monitoring Devices Market size is projected to grow at a CAGR of over 12.0% during the forecast period, from USD 22.36 billion in 2018, and reach an estimated value of around USD 29.61 billion by 2028 end. The factors driving this growth are the rising incidence rate of cardiovascular disorders as well as the aging population which increases the burden on healthcare providers to monitor the patient condition for early diagnosis and treatment management purposes; increasing awareness about prevention benefits that come with implantable monitors such as improved quality-of-life (QOL) due to increased freedom and pleasure from participating in everyday activities without fear or worry about sudden death/cardiac arrest.
Cardiac Arrhythmia Monitoring Devices are the tools or equipment that use electrical impulses to monitor and detect any abnormalities in the heart rhythm. Cardiac arrhythmias are abnormal rhythms of the heartbeat, which can cause life-threatening conditions such as sudden cardiac arrest (SCA).
On the basis of Type, the market is segmented into Implantable Cardiac Monitors, Resting ECG Devices, ECG Stress Test Devices, Mobile Cardiac Telemetry Monitors, Holter Monitors.
Implantable Cardiac Monitors are devices that monitor a person’s heart rhythm and send the data to a computer. They can also detect arrhythmias (abnormal rhythms) or other conditions such as atrial fibrillation, ventricular tachycardia, long QT syndrome, and Wolff-Parkinson-White Syndrome. Implantable Cardiac Monitors are used to help diagnose and treat heart rhythm disorders.
The largest segment for this type is the North American region followed by Europe. It has been growing steadily due to the increasing prevalence of arrhythmias across various age groups especially amongst geriatric patients as well as significant advancements in technology such as miniaturization which reduces surgical risks while maintaining accuracy; expanding application areas like homecare settings (home monitoring), Emergency Medical Services (EMS) ambulances, etc., along with emerging markets like Latin America.
This type of monitoring device records ECG readings while one is resting (in either sitting or supine position). It offers information about changes in rhythms over time but does not provide any indication of what caused the occurrence of such a phenomenon. Resting ECG devices are used for a general health screening with generally low-risk factors which make them appropriate for most adults without any pre-existing cardiovascular conditions.
ECG Stress Test Devices are devices that measure the heart’s electrical activity in response to a stressor. The typical method for performing an ECG stress test is by attaching electrodes on the patient’s chest or limbs and connecting them to an electrocardiograph machine. This device collects resting electrocardiograph (ECGs) readings from the patients by the end during a period of time, which is typically 24 hours.
Mobile Cardiac Telemetry Monitor records data while patients actively engage in exercise at different levels of intensity. This information may help doctors to assess cardiovascular response during daily life activities such as walking, climbing stairs, or more demanding tasks like running on a treadmill for 30 minutes.
The Mobile Cardiac Telemetry Monitors segment is a sub-segment of the market, which tracks heart activity. These devices are used to monitor patients who have chronic cardiac problems and need constant care such as those with arrhythmia or pacemaker implantations.
A Holter monitor is a portable, battery-powered device that records an electrocardiogram continuously for up to 24 hours. It can be used in the diagnosis of various heart problems such as arrhythmia or cardiac arrest, and also to detect atrial fibrillation (a type of irregular heartbeat). A patient should not wear a Holter monitor if he has certain conditions including pacemaker implantation within the past 30 days, intraventricular conduction defects on previous ECGs within 60 days; severe kidney failure with creatinine clearance less than 15 mL per minute; chest pain when lying down or standing still lasting more than five minutes without relief from nitroglycerin tablets.
On the basis of Application, the market is segmented into Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Homecare Settings, and Emergency Medical Services.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North American market is projected to be the largest and fastest-growing regional market for cardiac arrhythmia monitoring devices. The region is anticipated to lead in terms of revenue generation, owing to a large number of hospitals and diagnostic centers present in the US; moreover, technological advancements coupled with increasing awareness among clinicians would also drive growth in this region over the forecast period.
The Asia Pacific & Middle East & Africa markets are expected to grow at high rates during the forecast period owing to an increase in healthcare expenditure per capita on account of government initiatives such as the National Health Protection Scheme which was launched recently. Europe has been witnessing sluggish performance due to stringent regulatory norms hampering medical device innovation, lack of an adequate skilled workforce available across the region.
Up Market Research published a new report titled “Cardiac Arrhythmia Monitoring Devices Market research report which is segmented by Types (Implantable Cardiac Monitors, Resting ECG Devices, ECG Stress Test Devices, Mobile Cardiac Telemetry Monitors, Holter Monitors), By Applications (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Homecare Settings, Long Term Care Centers, Emergency Medical Services), By Players/Companies NUUBO, Koninklijke Philips, General Electric, Hill-Rom, OSI Systems, Nihon Kohden, Fukuda Denshi, Biotelemetry, AliveCor, Biotronik, Medronic, Abbott”.
|Report Attributes||Report Details|
|Report Title||Cardiac Arrhythmia Monitoring Devices Market Research Report|
|By Type||Implantable Cardiac Monitors, Resting ECG Devices, ECG Stress Test Devices, Mobile Cardiac Telemetry Monitors, Holter Monitors|
|By Application||Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Homecare Settings, Long Term Care Centers, Emergency Medical Services|
|By Companies||NUUBO, Koninklijke Philips, General Electric, Hill-Rom, OSI Systems, Nihon Kohden, Fukuda Denshi, Biotelemetry, AliveCor, Biotronik, Medronic, Abbott|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||223|
|Number of Tables & Figures||157|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Implantable Cardiac Monitors, Resting ECG Devices, ECG Stress Test Devices, Mobile Cardiac Telemetry Monitors, Holter Monitors and By Application Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Homecare Settings, Long Term Care Centers, Emergency Medical Services.
Some of the companies that are profiled in this report are:
Cardiac Arrhythmia Monitoring Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Cardiac Arrhythmia Monitoring Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Cardiac Arrhythmia Monitoring Devices Market Report:
Some other reports from this category!